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Occupational exposure to asphalt fumes may pose a
health risk. Experimental studies using animal and in
vitro models indicate that condensates from asphalt
fumes are genotoxic and can promote skin tumorigene-
sis. Enhanced activity of activator protein-1 (AP-1) is
frequently associated with the promotion of skin tumor-
igenesis. The current study investigated the effect of
exposure to asphalt fumes on AP-1 activation in mouse
JB6 P epidermal cells and the skin of transgenic mice
expressing the AP-1 luciferase reporter gene. Asphalt
fumes were generated from a dynamic generation sys-
tem that simulated road-paving conditions. Exposure to
asphalt fumes significantly increased AP-1 activity in
JB6 P cells as well as in cultured keratinocytes isolated
from transgenic mice expressing AP-1 reporter. In addi-
tion, topical application of asphalt fumes by painting
the tail skin of mice increased AP-1 activity by 14-fold.
Exposure to asphalt fumes promoted basal as well as
epidermal growth factor-stimulated anchorage-inde-
pendent growth of JB6 P cells in soft agar. It activated
phosphatidylinositol 3-kinase and induced phosphoryl-
ation of Akt at Ser-473/Thr-308, and concurrently acti-
vated downstream p70 S6 kinase as well as glycogen
synthase kinase-3. Asphalt fumes transiently activated
c-Jun NH2-terminal kinases without affecting extracel-
lular signal-regulated kinases and p38 mitogen-acti-
vated protein kinases. Further study indicated that
blockage of phosphatidylinositol 3-kinase activation
eliminated asphalt fume-stimulated AP-1 activation and
formation of anchorage-independent colonies in soft
agar. This is the first report showing that exposure to
asphalt fumes can activate AP-1 and intracellular sig-
naling that may promote skin tumorigenesis, thus pro-
viding important evidence on the potential involvement
of exposure to asphalt fumes in skin carcinogenesis.
Millions of tons of asphalt are produced every year and
extensively used in the paving and roofing industries (1). It has
been estimated that 2 million workers are exposed to asphalt
fumes (1). It was reported that road-paving workers can be
exposed to 0.1–2 mg/m3 of bitumen fumes, which can include
10–200 ng/m3 benzo(a)pyrene (2). The worker exposure routes
are mainly through inhalation and skin contamination. Pro-
longed, extensive exposure to asphalt fumes has been reported
to be associated with several adverse health effects (3). A major
health concern from exposure to asphalt fumes is the potential
exposure to carcinogens. Epidemiological studies indicate that
there is an increased risk for lung, stomach, nonmelanoma skin
cancer, and leukemia in the roofer population (4). Experimen-
tal studies using animal and in vitro models demonstrate that
laboratory-generated condensates from roofing asphalt fumes
are genotoxic and produce skin tumors in mice (5, 6). Exposure
to several other asphalt-based paints causes the formation of
DNA adducts in the skin and lung of mice as well as in human
skin fibroblast (7). However, the information regarding the
potential carcinogenic effect of asphalt fumes is very limited.
Chemical carcinogenesis is a complex process that can be
divided experimentally into three stages: initiation, promotion,
and progression. Initiation is associated with irreversible, car-
cinogen-mediated DNA mutation. In contrast, promotion is a
reversible process in which there are increases in the rate of
cell replication and/or alterations in gene expression. Progres-
sion represents the final genetic changes associated with the
conversion of benign tumors into fully malignant cells. JB6 P
mouse epidermal cell line (Cl 41), originally derived from pri-
mary mouse epidermal cells, offers an excellent model to inves-
tigate the molecular events that are associated with tumor
promotion. These cells undergo a response analogous to second
stage tumor promotion in mouse skin when treated with vari-
ous tumor promoters. For example, exposure of JB6 P cells to
12-O-tetradecanoylphorbol 13-acetate or epidermal growth fac-
tor (EGF)1 induces phenotype of anchorage-independent
growth and tumorigenicity in vivo (8–10). These cells have
been used extensively as an in vitro model for the promotion of
neoplastic transformation (9–13).
AP-1 is a basic leucine zipper transcription factor that is
composed of homodimer or heterodimer proteins of the Jun,
Fos, or ATF families (14). AP-1 regulates the expression of a
diverse array of genes, including those involved in cell growth,
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proliferation, and transformation (14–16). It has been demon-
strated that the activation of AP-1 is essential for the promo-
tion of skin tumorigenesis (17–21). The activation of AP-1 is
regulated by multiple signaling pathways, including phos-
phatidylinositol-3 kinase (PI3K)/Akt and mitogen-activated
protein kinase (MAPK) pathways. A recent study indicates that
AP-1 activity is also regulated by glycogen synthase kinase-3
(GSK-3) signaling (22). These signal pathways have been
shown to play a critical role in promotion of skin tumorigenesis
(18, 23–27). The current study was designed to evaluate the
effect of exposure to asphalt fumes on AP-1 activity and asso-
ciated intracellular signaling. Asphalt fumes were generated
from a dynamic asphalt-fume generation system that simu-
lates road-paving conditions (28). We demonstrate here that
exposure to asphalt fumes induces AP-1 transactivation in JB6
P cells as well as in skin and primary keratinocytes derived
from transgenic mice expressing AP-1 reporter gene; it selec-
tively activates PI3K/Akt and c-Jun NH2-terminal kinase
(JNK) pathways. Furthermore, exposure to asphalt fumes pro-
motes anchorage-independent growth in soft agar. These re-
sults provide an important insight into the potential role of
exposure to asphalt fumes in tumor promotion.
MATERIALS AND METHODS
Materials—Reagent grade dichloromethane (CH2Cl2, 99.9%), hex-
ane, and perdeuterated anthracene were purchased from Aldrich. The
PAH mix reference material was purchased from Supelo (Bellefonte,
PA). The test asphalt was the type used by the paving industry (Hot
Performance Grade Asphalt PG 64-22). The glass-fiber filters (20.3 
25.4 cm) were purchased from Gelman Sciences (Ann Arbor, Michigan).
Solid phase extraction cartridges of EnvirElut PAH (500 ng/2.8 ml)
were purchased from Varian (Harbor City, CA). Poly(tetrafluoroethyl-
ene tubes (30 ml) and glass tubes (10 ml) were purchased from Fisher
Scientific. Target vials (1.5 mm with 200-l inserts) were obtained from
Alltech Associates, Inc. (Deerfield, IL). Extraction of asphalt fumes
from collection media was performed by ultrasonic extraction (FS-220,
Ultrasonicator 320W; Fisher Scientific). Extracts were reduced under a
nitrogen stream using a TurboVap LV evaporator (Zymark). High pu-
rity helium was purchased from Butler Gas Products Co. (Mckees
Rocks, PA), and used as gas chromatography/mass spectrometry
(Hewlett Packard, Wilmington, DE) carrier gas. The GC column was
HP-5 MS, 95% dimethylpolysiloxane, nonpolar, 30-m length, 0.53 mm
inner diameter (Hewlett Packard). All antibodies except anti-actin and
anti-p110 subunit of PI3K antibodies were obtained from Cell Signaling
Technology, Inc. (Beverly, MA). Anti-actin and anti-p110 antibodies
were purchased from Santa Cruz Biotechnology (Santa Cruz, CA).
Preparation of Asphalt Fume Samples—Generation of asphalt fumes
was conducted in the National Institute for Occupational Safety and
Health inhalation facility. A dynamic asphalt fume generation system
was employed to provide test asphalt fumes (28). A computer control
system has been designed to improve the system’s performance and to
simplify its operation. The test asphalt is representative of the type
used by the paving industry throughout the midwestern United States.
The asphalt fumes were generated at 150 °C, and collected on glass-
fiber filters. The fumes sample preparation involved desorption, filtra-
tion, and preconcentration. In the experiment, the asphalt fumes col-
lected on filter were transferred to a poly(tetrafluoroethylene) tube, and
dichloromethane/hexane (50/50) was added. Ultrasonic extraction was
performed using an FS-220 Ultrasonicator (320W). After desorption of
asphalt fumes from the collection medium, the extract was filtered.
Preconcentration was performed under nitrogen using TurboVap LV
Evaporator. Sample extracts were reconstituted with dichloromethane.
Culture and Treatment of Mouse Epidermal Cell Lines—JB6 P
mouse epidermal cell line (Cl 41) were grown in Eagle’s minimal essen-
tial medium containing 10% fetal bovine serum (FBS), 2 mM L-gluta-
mine, and 25 g/ml gentamicin at 37 °C with 5% CO2. The stable
transfectants of Cl 41 cells expressing AP-1-luciferase reporter (Cl 41
AP-1) and dominant-negative PI3K regulatory p85 subunit (JB6DNp85)
have been described previously (24). Cells were exposed to asphalt
fumes (10–320 g/ml) for specified periods. For blocking intracellular
kinase activity, cells were treated with either PI3K inhibitor (10 M
LY294002 or 100 nM wortmannin; Sigma), GSK-3 inhibitor (10 M
4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione; Calbiochem), or JNK
inhibitor (1 M D-JNKI; Alexis Biochemicals, San Diego, CA) 30 min
before exposure to asphalt fumes.
AP-1-luciferase Reporter Transgenic Mice and Keratinocyte Cul-
ture—2X TRE-luciferase reporter transgenic mice were originally es-
tablished by Rincon and Flavell (29). A C57BL/6 male mouse carrying
the 2X TRE-luciferase transgene was crossed with DBA/2 female mice
(SASCO, Omaha, NE) (18). The F1 offspring were screened by testing
both the basal and 12-O-tetradecanoylphorbol 13-acetate-induced levels
of luciferase activity for the presence of the AP-1-luciferase reporter
gene. Mice were housed under temperature-, humidity-, and light-
controlled conditiona. Food and water were available ad libitum.
Primary mouse epidermal keratinocytes were isolated from the epi-
dermis of newborn AP-1 transgenic mice by a method described previ-
ously (30, 31). Briefly, the trunk skin of newborn mice was floated
dermis side down on 0.25% trypsin/EDTA in Dulbecco’s phosphate-
buffered saline solution overnight at 4 °C, and the epidermal layer was
separated. The epidermis was minced in keratinocyte essential medium
(Sigma), and then the cell suspension was filtered through a 70-m cell
strainer to remove the stratum corneum. Keratinocytes were collected
by centrifugation (500  g, 10 min) and seeded into fibronectin/colla-
gen-coated dishes. Cells were maintained in a keratinocyte growth
medium (Sigma) for 4 h with 5% CO2 at 37 °C. Unattached cells were
removed by a gentle wash with warm keratinocyte growth medium.
Adhesive keratinocytes were cultured in this medium at 37 °C in a
humidified atmosphere of 5% CO2.
Measurement of AP-1 Activity—AP-1 transactivation in JB6 P epi-
dermal cells was determined by assaying the activity of the luciferase
reporter (24). Briefly, cells were cultured in 96-well plates and grown in
a medium containing 10% FBS. The plates were incubated at 37 °C in
a humidified atmosphere of 5% CO2. For assaying AP-1 activity, sub-
confluent cultures were maintained in a medium containing 0.1% FBS
for 24 h and subsequently treated with asphalt fumes with or without
protein kinase inhibitors for specified durations. After treatment, cel-
lular protein was extracted with a 1 lysis buffer supplied in the
luciferase assay kit (Promega), and luciferase activity was measured
with a Monolight luminometer (Analytical Luminescence Laboratory,
Sparks, MD). AP-1 activity (luciferase activity) was calculated and
expressed relative to the untreated cultures. AP-1 activity was also
measured in purified primary keratinocytes and the skin of transgenic
mice expressing AP-1 luciferase reporter gene. Primary epidermal ke-
ratinocytes were exposed to asphalt fumes (10 g) for 6 h, and AP-1
activity was determined. For assay of AP-1 activity in mouse skin, a
small piece of tail skin (2 mm2) was removed either before or after
asphalt painting, and cellular protein was extracted with a 2 lysis
buffer, then luciferase activity was assayed as above.
MTT Assay—The 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyl tetrazo-
lium bromide (MTT) assay was employed to determine the number of
viable cells in culture (Roche Molecular Biochemicals) (32). The assay is
based on the cleavage of the yellow tetrazolium salt MTT to purple
formazan crystals by metabolically active cells. Briefly, the cells were
plated into 96-well microtiter plates and exposed to either asphalt
fumes (10–320 g/ml) or Me2SO (control) for 48 h. After exposure to
asphalt fumes, 10 l of MTT labeling reagent were added to each well,
and the plates were incubated at 37 °C for 4 h. The cultures were then
solubilized, and spectrophotometric absorbance of the samples was
detected by a microtiter plate reader. The wavelength to measure
absorbance of formazan product is 570 nm, with a reference wavelength
of 750 nm.
PI3K Activity—Cells were washed with ice-cold phosphate-buffered
saline, scraped from the plates, and centrifuged at 4000 cpm for 5 min.
The cell pellet was incubated for 30 min on ice in lysis buffer (150 mM
NaCl, 100 mM Tris-HCl, pH 8.0, 1% Triton X-100, 5 mM EDTA, and 10
mM NaF) supplemented with 1 mM dithiothreitol, 1 mM phenylmethyl-
sulfonyl fluoride, 1 mM sodium vanadate, 2 mM leupeptin, and 2 mM
aprotinin, and centrifuged at 15,000  g for 15 min. PI3K was immu-
noprecipitated using a method described previously (33). Briefly, 400 g
of total protein was incubated with 20 l of protein A/G plus agarose for
1 h at 4 °C, followed by spinning at 3000 cpm for 3 min. The superna-
tant was then incubated with 10 l of antibody directed against p110
subunit of PI3K (Santa Cruz Biotechnology) overnight at 4 °C. Protein
A/G-agarose beads (30 l) were added for an additional 1 h. The beads
were then pelleted and washed sequentially, five times, with 20 mM
Tris, pH 7.5, 100 mM NaCl, and 1 mM EDTA) and once with 20 mM
HEPES. PI3K activity assay was performed using phosphatidylinositol
as substrate in a final volume of 50 l containing 20 mM HEPES, pH
7.5, 10 mM MgCl, 2 Ci of [32P]ATP, 60 M ATP, and 0.2 mg/ml
sonicated phosphatidylinositol. Reaction was carried out for 15 min at
room temperature and extracted by the addition of 80 l of 1 M HCl and
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160 l of chloroform/methanol (1:1). After centrifugation at 3000 cpm
for 2 min, the organic phase (bottom layer) was collected and dried in
with a vacuum drier (SpeedVac, Thermo Savant, Holbrook, NY). The
samples were dissolved in 10 l of chloroform and separated on a thin
layer chromatography plate. Incorporation of 32P into phosphorylated
lipids was detected by autoradiography for 1–2 days.
Immunoblotting—The immunoblotting procedure for detecting phos-
phorylation and expression of signal proteins was performed as de-
scribed previously (33). Briefly, cells were washed with phosphate-
buffered saline and lysed with radioimmunoprecipitation assay buffer
for 10 min, solubilized cells were centrifuged, the supernatant was
collected, and the protein concentration was determined. Aliquots of the
protein (40 g) were loaded onto the lanes of an SDS 10.0% polyacryl-
amide gel. The proteins were separated by electrophoresis, and the
separated proteins were transferred to nitrocellulose membranes. The
membranes were blocked with either 5% nonfat dry milk or 5% bovine
serum albumin (for detection of phosphorylation) in 0.010 M phosphate-
buffered saline, pH 7.4, and 0.05% Tween 20 at room temperature for
1 h to block nonspecific immunoreactivity. Subsequently, the mem-
branes were incubated with primary antibodies directed against signal
proteins for 1.5 h at room temperature. After two quick washes in
phosphate-buffered saline and 0.05% Tween 20, the membranes were
incubated with a secondary antibody conjugated to horseradish perox-
idase (Amersham Biosciences) diluted at 1:2000 in phosphate-buffered
saline and 0.05% Tween 20 for 1 h. The immune complexes were
detected by the enhanced chemiluminescence method (Amersham Bio-
sciences). In some cases, the blots were stripped and re-probed with an
anti-actin antibody (Santa Cruz Biotechnology).
Anchorage-independent Growth—The cell growth matrix consists of
two layers of basal medium Eagle agar in 6-well culture trays. The base
layer (2 ml) contained 10% FBS and 0.5% basal medium Eagle agar.
The top layer (0.5 ml) contained 10% FBS, 0.33% basal medium Eagle
agar, and JB6 P or JB6DNp85 cell suspension (0.5  104). EGF (30
ng/ml) and asphalt fumes (10 ng/ml) were applied in both the top and
bottom layers. The cultures were maintained at 37 °C with an atmo-
sphere of 5% CO2 for 14 days, and the number of induced cell colonies
was counted under a microscope. Colonies, which contain 8 or more
cells, were counted in four 0.5-cm2 areas randomly chosen with respect
to distance from the center of the well, and the count was multiplied by
the appropriate factor to give the colony number/well.
Statistical Analysis—Differences among treatment groups were tested
using an analysis of variance. Differences in which p was less than 0.05
were considered statistically significant. In cases where significant differ-
ences were detected, specific post hoc comparisons between treatment
groups were examined with Student-Newman-Keuls tests.
RESULTS
Determination of Asphalt Fume Concentration—The concen-
tration of asphalt fumes was determined by gas chromatogra-
phy/mass spectrometry with positive electron ionization. The
instrument was calibrated with the use of a mixture of 16
reference PAHs, and perdeuterium anthracene was used as
internal standard. The total ion chromatograms were acquired
with a 3-min solvent delay. Separation was performed on a
HP-5 MSD capillary column (30-m length, 0.53 mm inner di-
ameter) with a temperature program from 50–310 °C at an
increasing rate of 5 °C/min. Calibration curves were developed
with five-point measurements. The recovery of the asphalt
fumes were evaluated by adding stable isotope perdeuterated
anthracene in the samples and determined by gas chromatog-
raphy/mass spectrometry. The analytical results were recorded
as profiles of total ion chromatogram over specific ranges of
mass-to-charge ratios. A typical total ion chromatogram ac-
quired is displayed in Fig. 1A. The major components were
observed over a range of molecular size of m/z 51–365 (Fig. 1, B
and C), and eluted from capillary column at retention times of
13–52 min. The relative recovery of the internal standard can
account for losses of the analytes during sample preparation
and detection. The total asphalt fume concentration was deter-
mined and diluted to 41.41 mg/ml with Me2SO for cell expo-
FIG. 1. Determination of asphalt fumes concentration. A, total ion chromatogram of asphalt fumes collected on glass-fiber filters acquired
by positive electron ionization gas chromatography/mass spectrometry. B, mass spectrum corresponding to retention time of 15.0 min. C, mass
spectrum corresponding to retention time of 50.2 min.
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sure. In some cases, asphalt fumes were dissolved in ethanol
for comparison.
Exposure to Asphalt Fumes Activates AP-1—MTT assay was
performed to determine whether asphalt fumes, at a pharma-
cologically relevant concentration range, affect cell viability. As
shown in Fig. 2, at the concentration less than 40 g/ml, as-
phalt fumes did not significantly affect the viability of JB6 P
cells; however, at high concentrations (40 g/ml), asphalt
fumes caused cell death regardless of serum concentration in
the culture medium. In all the subsequent studies, therefore, a
non-toxic concentration of asphalt fumes (20 g/ml) was used.
Exposure to asphalt fumes significantly stimulated AP-1 activ-
ity in JB6 P cells, and maximal activation occurred at 12 to
24 h after treatment with asphalt fumes (Fig. 3A). Further-
more, exposure to asphalt fumes dramatically increased AP-1
activity in the skin and purified keratinocytes of transgenic
mice expressing AP-1 reporter gene (Fig. 3B).
Exposure to Asphalt Fumes Activates PI3K/AKT Signaling
Pathway—The activity of AP-1 is regulated by multiple signal-
ing pathways. Among these pathways, PI3K- and MAPK-me-
diated signaling plays a critical role. Therefore, we sought to
determine whether asphalt fumes affected PI3K and MAPKs.
As shown in Fig. 4A, exposure to asphalt fumes activated PI3K,
and maximal activation occurred at 1–2 h after exposure. How-
ever, asphalt fumes did not affect the phosphorylation and
expression of phosphatase and tensin homologue deleted on
chromosome-10 (PTEN), a dual-specificity phosphatase that
dephosphorylates PtdIns(3,4,5)P3 (Fig. 4B), suggesting that the
effect of asphalt fumes is not mediated by the inhibition of
dephosphorylation. One major substrate of PI3K is PKB/Akt.
Activated PI3K stimulates phosphoinositide-dependent ki-
nase-1/-2, which in turn phosphorylates Akt on Thr-308 and
Ser-473 (34, 35). As shown in Fig. 5A, exposure to asphalt
fumes induced phosphorylation of Akt at Ser-473 and Thr-308.
We further investigated whether the activation of Akt is medi-
ated by PI3K. Blockage of PI3K by a specific inhibitor,
LY294002, eliminated asphalt fume-mediated phosphorylation
of Akt (Fig. 5B). A similar blocking effect was observed when
wortmannin, another PI3K inhibitor, was applied (data not
shown). In addition, inhibition of PI3K activation by expressing
dominant-negative p85 (regulatory subunit of PI3K) also
blocked asphalt fume-induced Akt activation (Fig. 5C). To de-
termine whether different solvents may affect biological activ-
ity of asphalt fumes, we dissolved asphalt fumes with ethanol.
Effect of ethanol-dissolved asphalt fumes on signal transduc-
tion was evaluated, and the results were similar to those of
Me2SO-dissolved asphalt fumes (data not shown).
Next, we sought to determine whether exposure to asphalt
fumes activated downstream components of Akt. Three major
downstream effectors of Akt (GSK-3, p70 S6 kinase, and fork-
head transcription factor) were examined. Exposure to asphalt
fumes induced phosphorylation of GSK-3 on Ser-9 (Fig. 6A)
without affecting phosphorylation on Tyr-216 (data not shown).
The antibody directed against phospho-p70 S6 kinase (Thr-421/
Ser-424; Cell Signaling Inc.) also reacted with phospho-p85 S6
kinase. Exposure to asphalt fumes increased phosphorylation
of p85 S6 kinase and p70 S6 kinase on Thr-421/Ser-424 (Fig.
6A), but not on Thr-389 (data not shown). However, exposure to
asphalt fumes did not affect the phosphorylation of forkhead
transcription factor, a distal component of PI3K/Akt signaling
pathway. Blockage of PI3K activity by LY294002 eliminated
asphalt fume-mediated phosphorylation of p85 S6 kinase and
p70 S6 kinase, and partially inhibited asphalt fume-induced
GSK-3 (Fig. 6, B and C).
The effect of exposure to asphalt fumes on MAPK was exam-
ined. As shown in Fig. 7, asphalt fumes induced a transient
activation of JNKs, which lasted for only 15 min, and modestly
enhanced phosphorylation of c-Jun. In contrast, asphalt fumes
did not affect the phosphorylation of either p38 MAPK or
ERKs.
PI3K/Akt Signaling Pathway Mediates Asphalt Fume-stimu-
lated AP-1 Activity and Anchorage Independence—To deter-
mine which signaling pathway was involved in asphalt fumes-
stimulated AP-1 activation, we used specific inhibitors to block
the activity of kinases that may regulate AP-1 activity. As
shown in Fig. 8, treatment with the PI3K inhibitor LY294002
completely eliminated asphalt fume-stimulated AP-1 activity.
Similarly, another PI3K inhibitor, wortmannin, also blocked
asphalt fume-induced AP-1 activation (data not shown). 4-Ben-
zyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione is a specific GSK-3
inhibitor (36). As shown in Fig. 8, 4-benzyl-2-methyl-1,2,4-thia-
diazolidine-3,5-dione partially but significantly blocked AP-1
activity. D-JNKI is a specific JNK inhibitor, and we have shown
FIG. 2. Effect of asphalt fumes on the viability of JB6 P cells.
Cells were grown in either serum-free medium or medium containing
10% serum and exposed to asphalt fumes (AF; 0–320 g/ml) dissolved
in Me2SO for 48 h. The controls were exposed to Me2SO. The viability
of cells was determined by MTT assay as described under “Materials
and Methods.” Each data point is the mean of five replicates  S.E.
(bars). *, p  0.05, statistically significant difference between control
and asphalt fume-treated cells.
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previously that it eliminates JNK activity (37). D-JNKI had
little effect on asphalt fume-mediated AP-1 activation. The
effect of other MAPK inhibitors was also examined. Neither
SB202190 (inhibitor for p38 MAPK) nor PD98059 (inhibitor for
MEK1) altered asphalt fume-regulated AP-1 activity (data not
shown).
Effect of asphalt fumes on transformation of JB6 P cells
was examined by assaying anchorage-independent growth. It
has been shown that tumor promoter 12-O-tetradecanoyl-
phorbol 13-acetate and epidermal growth factor (EGF) pro-
mote anchorage-independence of JB6 P cells (23). As shown
in Fig. 9, asphalt fumes promoted basal as well as EGF-
mediated anchorage-independent growth. However, in JB6
P cells constitutively expressing dominant-negative p85
(JB6DNp85), asphalt fumes were ineffective. Thus, PI3K was
an essential component for asphalt fume-promoted JB6 P cell
transformation.
DISCUSSION
Asphalt is an extremely complex and variable mixture. It
contains aliphatic PAHs, heterocyclic compounds, and some
nitrogen-, oxygen-, and sulfur-containing compounds (5). These
persistent organic compounds are very nonpolar and exhibit a
high accumulation potential in living systems (38). The highly
lipophilic PAH chemicals constitute an extraordinarily large
and diverse class of organic molecules and represent compo-
nents with a wide range of molecular sizes and structural
types. It has been estimated that that crude asphalt contains
the most widely distributed class of potent carcinogens present
in the human environment (39). To evaluate adverse biological
FIG. 3. Effects of asphalt fumes on AP-1 activity. A, AP-1 activity in JB6 P cells. Cells were exposed to asphalt fumes (AF, 0 or 20 g/ml)
for 6–48 h. AP-1 activity was determined as described under “Materials and Methods.” Each data point is the mean of four replicates S.E. (bars).
B, AP-1 activity in transgenic mice expressing AP-1 reporter gene. Skin of transgenic mice was painted with asphalt fumes for 24 h. Equal areas
of skin (2 mm2) were removed before and after asphalt fume painting and assayed for AP-1 activity. Purified keratinocytes from transgenic mice
were cultured as described under “Materials and Methods” and exposed to asphalt fumes (10 g/ml, 6 h). AP-1 activity in keratinocytes was
determined as described above. Each data point is the mean of four independent trials  S.E. (bars). *, p  0.05, statistically significant difference
between control and asphalt fume-treated samples.
FIG. 4. Effect of asphalt fumes on PI3K activity in JB6 P cells. A, PI3K activity. JB6 P cells were grown in serum-free medium for 24 h
and exposed to asphalt fumes (AF, 20 g/ml). PI3K was immunoprecipitated and the kinase activity was measured in the immunocomplexes using
phosphatidylinositol and [32P]ATP as substrates. The products were separated by thin layer chromatography and subjected to autoradiography
as described under “Materials and Methods.” B, phosphorylation of PTEN. The phosphorylation of PTEN on Ser-380 was determined with
immunoblot using a phosphospecific antibody. The same blot was striped and reprobed with either an anti-PTEN or an anti-actin antibody. The
experiments were replicated three times.
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effects of asphalt fumes in occupational exposure, we have
established a computer-controlled dynamic asphalt fume gen-
eration system in which asphalt fumes can be generated under
simulated road-paving conditions (28). We have also developed
a highly sensitive, selective, and reliable analytical method to
characterize the contents of asphalt fumes generated under
these conditions (28). Human skin receives much occupational
exposure to asphalt fumes. We are therefore interested in ex-
amining the effect of exposure to asphalt fumes on epidermal
cells.
Exposure to asphalt fumes activates AP-1 in a mouse epider-
mal cell line as well as in the skin and primary keratinocytes
derived from transgenic mice. Furthermore, asphalt fumes pro-
mote cell transformation. Up-regulation of AP-1 activity is
frequently associated with cell transformation, and blockage of
AP-1 activity has been shown to reverse the transformation of
mouse epidermal cells (10, 13, 17, 18, 40). Many intracellular
signaling pathways either directly or indirectly regulate AP-1
activation and cell transformation. Our results indicate that
PI3K is necessary for asphalt fume-induced AP-1 activation as
well as cell transformation; blockage of PI3K by chemical in-
hibitors or expression of dominant-negative PI3K abolishes
asphalt fume-mediated AP-1 activation as well as cell transfor-
mation. It is interesting to note that blockage of GSK-3 activ-
ity partially inhibits asphalt fume-induced AP-1 activation,
suggesting that GSK-3 signaling pathway may also contrib-
ute to asphalt fume-induced AP-1 activation even though not a
primary one. This observation is supported by recent studies
demonstrating that GSK-3 regulates AP-1 activity and is
involved in skin tumorigenesis (22, 26). Three members of the
MAPK family (JNKs, p38 MAPK, and ERKs) are known to be
important mediator of AP-1 activity and play a critical role in
skin tumorigenesis (14, 24, 27). However, they are minimally
involved in asphalt fume-induced AP-1 activation. Although
JNKs are modestly and transiently activated by asphalt fumes,
the extent of activation apparently does not lead to AP-1 acti-
vation; blockage of JNK activation has little effect on asphalt
fume-induced AP-1 activation. Asphalt fumes are ineffective in
the activation of p38 MAPK and ERKs, indicating that the
effect of asphalt fumes on intracellular signaling is somewhat
specific. As expected, blockage of either p38 MAPK or ERKs
does not affect asphalt fume-mediated AP-1 activation.
PI3K is an important signaling molecule consists of a het-
erodimer of a 110-kDa (p110) catalytic subunit and an 85-kDa
(p85) regulatory subunit. Upon activation, which is usually
triggered by the association with tyrosine kinases or G-protein-
coupled receptors, it phosphorylates phosphatidylinositol
(PtdIns) and generated phosphorylated derivative (phospho-
inositide), such as PtnIns(3) phosphate, PtdIns(3,4)P2 and
PtdIns(3,4,5)P3 (41). Phosphoinositides interact with the Pleck-
strin homology (PH) motif and subsequently activate PH do-
main containing proteins. Akt is among the first protein known
to contain a PH domain. PH domain of Akt specifically binds
PI3K lipid products PtdIns(3,4)P2 and PtdIns(3,4,5)P3. Resting
cells contain substantial levels of PtnIns(3) phosphate, but
hardly any PtdIns(3,4)P2 and PtdIns(3,4,5)P3. Upon activation
of PI3K, PtdIns(3,4)P2 and PtdIns(3,4,5)P3 are synthesized at
plasma membrane and interact with Akt through its PH do-
main. This induces (1) the translocation of Akt to the plasma
membrane and (2) a conformational change that exposes Thr-
308 (kinase domain) and Ser-474 (C-terminal regulatory do-
main) phosphorylation sites at Akt. The phosphorylation of Akt
was then catalyzed by PDK1 at plasma membrane (41). Phos-
phorylation of both these residues is essential for maximal
activation of Akt in response to PI3K activation. Our result
indicates that asphalt fumes enhance PI3K activity and stim-
ulate phosphorylation of Akt on both Thr-308 and Ser-473
without affecting the expression and phosphorylation of PTEN.
PTEN antagonizes the action of PI3K activity by dephospho-
rylating PtdIns(3,4,5)P3 (42). Thus, asphalt fume-induced Akt
FIG. 5. Effects of asphalt fumes on Akt activation in JB6 P and JB6DNp85 cells. A, Akt phosphorylation. Cells were grown in a serum-free
medium for 24 h. After serum starvation, cells were treated with asphalt fumes (AF, 20 g/ml) for various times (5–120 min). Phosphorylation
(Ser-473 and Thr-308) and expression of Akt were determined with immunoblot using specific antibodies against either phosphorylated or regular
forms of Akt. B, effect of LY294002 on asphalt fume-induced Akt activation. JB6 P cells were pretreated with LY294002 (0 or 10 M) for 30 min
and exposed to asphalt fumes. Phosphorylation of Akt was determined with immunoblot as described above. C, phosphorylation and expression of
Akt in JB6DNp85 cells. The JB6 P cells stably expressing dominant-negative p85 subunit of PI3K (JB6DNp85) were exposed to asphalt fumes (20
g/ml), and phosphorylation of Akt was determined as described above. The experiments were replicated three to four times.
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activation is less likely to be mediated by an inhibition of
PTEN. A number of studies have documented PI3K-independ-
ent activation of Akt (41). Our study clearly demonstrates that
asphalt fume-induced Akt activation is PI3K-dependent; block-
age of PI3K activity abolishes asphalt fume-induced Akt
phosphorylation.
The mitogen-stimulated protein kinase p70S6K/p85S6K is a
Ser/Thr kinase that plays an essential role in cell proliferation
and growth. p70S6K phosphorylates the 40 S ribosomal protein
S6 and is involved in translational control of 5-oligopyrimidine
tract mRNAs (43, 44). p85S6K, an isoform of p70S6K, is de-
rived from the same gene and is identical to p70S6K except for
23 extra residues at the N terminus that encode a nuclear
localizing signal (43). The activation of p70S6K can be PI3K/
Akt-dependent or -independent (45). PI3K/Akt-dependent acti-
vation is mediated by mammalian target of rapamycin. Asphalt
fumes apparently promote phosphorylation of p70S6K/p85S6K
in a PI3K/Akt-dependent manner; blockage of PI3K eliminates
FIG. 6. Effect of asphalt fumes on Akt-regulated signaling in JB6 P cells. A, phosphorylation of downstream signal components of Akt.
Phosphorylation of p70/p85 S6 kinase (Thr-421/Ser-424), GSK-3 (Ser-9), and forkhead transcription factor (FKHR) (Ser-256) was determined with
immunoblots using phosphospecific antibodies. The same blots were striped and probed with an anti-actin antibody. Effect of LY294002 (LY) on
asphalt fume-induced activation of p70/p85 S6 kinase (B) and GSK-3 (C). JB6 P cells were pretreated with LY294002 (0 or 10 M) for 30 min
and exposed to asphalt fumes. Phosphorylation of p70 S6 kinase and GSK-3 was determined as described above. The experiments were replicated
three to four times.
FIG. 7. Effects of asphalt fumes on the activation MAP kinases
in JB6 P cells. Phosphorylation of JNKs, p38 MAPK, and ERKs was
investigated with immunoblots using phosphospecific antibodies. The
same blots were striped and probed with an anti-actin antibody. The
experiments were replicated three to four times.
FIG. 8. Effect of inhibitors for PI3K, JNKs, and GSK-3 on
asphalt fume-induced AP-1 activation in JB6 P cells. JB6 P
cells were pretreated with 10 M LY294002 (LY; PI3K inhibitor), 1 M
D-JNKI (JNKi; JNK inhibitor), and 10 M 4-benzyl-2-methyl-1,2,4-thia-
diazolidine-3,5-dione (GSKi; GSK-3 inhibitor) 30 min before AF expo-
sure. AP-1 activity was assayed 12 h after exposure to asphalt fumes.
The experiment was replicated four times. *, p  0.05, statistically
significant difference from untreated controls; **, p  0.05, statistically
significant difference from paired, asphalt fume-exposed groups. Ct,
control; DMSO, Me2SO.
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asphalt fume-induced phosphorylation of p70S6K/p85S6K.
GSK-3 was named for its ability to phosphorylate, and
thereby inactivate, glycogen synthase, a key regulatory process
in the synthesis of glycogen. Recent evidence indicates that
GSK-3, a critical figure in many cellular signaling pathways,
regulates cell proliferation, survival, and transformation (22).
In particular, GSK-3 has been implicated in skin tumorigen-
esis (26). GSK-3 activity is regulated by serine (inhibitory)
and tyrosine (stimulatory) phosphorylation. Asphalt fumes
stimulate GSK-3 phosphorylation on Ser-9, and this stimula-
tion is partially inhibited by LY294002, suggesting that the
PI3K/Akt pathway only partially contributes to the activation.
Serine phosphorylation of GSK-3 may be regulated by multi-
ple molecules. These include Akt, PKC, p90Rsk, and p70S6K
(22). Besides Akt, the kinase involved in asphalt fume-stimu-
lated GSK-3 phosphorylation is currently unknown.
In summary, this is the first report demonstrating that ex-
posure to asphalt fumes can activate AP-1 in the skin of mouse
and in cultured epidermal cells. Asphalt fumes also promote
anchorage-independent growth of mouse epidermal cells, sug-
gesting that exposure to asphalt fumes may favor cell transfor-
mation. The action of asphalt fumes is mainly mediated by the
PI3K/Akt signaling pathway. PI3K/Akt pathway has been
shown to play a critical role in tumor promotion and human
malignancy (46, 47). Thus, our study provides evidence show-
ing that asphalt fumes may be involved in carcinogenesis.
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FIG. 9. Effect of asphalt fumes on anchorage-independent
growth of JB6 P cells. JB6 P cells or JB6DNp85 cells, which were
grown in a matrix of soft agar, were exposed to AF (0 or 20 g/ml) plus
EGF (0 or 20 ng/ml). Cell colonies were scored after 14 days of incuba-
tion at 37 °C in an atmosphere of 5% CO2. The number of colonies was
expressed as an arbitrary unit relative to the untreated control group.
The experiment was replicated four times. *, p  0.05, statistically
significant difference from untreated controls. **, p  0.05, statistically
significant difference from paired, EGF-treated groups.
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